Retatrutide CAS NO.2381089-83-2

The mechanism of action of Retatrutide is characterized by its unique triple-agonist profile, which integrates the effects of three key metabolic hormones. By activating GLP-1 receptors, it enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner while slowing gastric emptying to increase satiety; through GIP receptor agonism, it improves insulin sensitivity and may potentiate the effects on adipose tissue; and critically, by activating the glucagon receptor, it increases energy expenditure and promotes lipolysis, thereby creating a synergistic effect that not only reduces appetite but also actively burns stored fat.

Retatrutide is indicated for the treatment of adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity, as well as for the management of type 2 diabetes mellitus. It is particularly suitable for patients seeking substantial weight loss beyond what is typically achievable with lifestyle modifications or first-line pharmacotherapies, including those who may be considering bariatric surgery but prefer a non-surgical alternative, and individuals requiring robust glycemic control alongside significant body weight reduction.

Clinical trial data, notably from the Phase 2 TRIUMPH study, demonstrate that Retatrutide achieves unprecedented levels of weight reduction, with up to 24.2% mean body weight loss at 48 weeks at the 12 mg dose, and over 30% weight loss observed in a significant proportion of participants at 72 weeks. For glycemic control, it achieved HbA1c reductions of up to 2.02%, significantly outperforming active comparators like dulaglutide. Furthermore, the product has shown efficacy in reducing liver fat content and improving cardiometabolic markers such as blood pressure and lipids, establishing it as a potent agent for comprehensive metabolic health.

Professional and Secure Packaging

Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation. We can also customize packaging according to customer needs.

Shipping Methods

Main Method: International Air Freight
We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Does Retatrutide Actually Burn Fat?

Retatrutide is an experimental medication being studied for obesity and metabolic disease. It activates three key hormone receptors: GLP-1, GIP, and glucagon. By stimulating GLP-1 and GIP pathways—similar to drugs like Tirzepatide—it significantly reduces hunger and food intake. At the same time, its glucagon receptor activity may slightly increase energy expenditure, meaning the body uses more calories at rest. This combination creates a sustained calorie deficit, which leads to fat loss.

Clinical studies have shown that people taking retatrutide can lose a substantial percentage of their body weight, much of which comes from fat mass rather than muscle. In summary, it creates biological conditions—reduced appetite and possibly increased energy use—that lead the body to gradually reduce stored fat.

Retatrutide Benefits

One of the most notable benefits is substantial weight loss, often exceeding what has been observed with earlier medications. Beyond weight management, retatrutide has demonstrated improvements in metabolic health, such as lowering blood glucose levels and improving insulin sensitivity. Another important benefit is its potential impact on cardiovascular risk factors and reducing liver fat, which may be beneficial for conditions like nonalcoholic fatty liver disease.

Retatrutide How to Get

Retatrutide is still an investigational drug, so you generally cannot obtain it through standard prescriptions or pharmacies at this time. The primary way to access retatrutide right now is through participation in clinical trials. It is important to be cautious about online sources claiming to sell retatrutide; any products marketed directly to consumers are likely unregulated and may be unsafe. The safest path to access is through properly conducted clinical research under medical supervision.